Are you Dr. McCallum?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 54 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4801 Alberta Ave
El Paso, TX 79905Phone+1 915-545-6618Fax+1 915-215-5386- Is this information wrong?
Summary
- Dr. Richard McCallum, MD is a gastroenterologist in El Paso, Texas. He is currently licensed to practice medicine in Texas, Florida, and Kansas. He is affiliated with University Medical Center of El Paso.
Education & Training
UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1972 - 1974
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1970 - 1972
The University of Queensland Medical SchoolClass of 1968
Certifications & Licensure
TX State Medical License 2014 - 2025
KS State Medical License 1996 - 2024
FL State Medical License 2014 - 2016
VA State Medical License 1985 - 2000- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients Start of enrollment: 2003 Oct 01
- Gastroparesis Registry Start of enrollment: 2006 Dec 01
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females Start of enrollment: 2007 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Current and emerging pharmacotherapy for the treatment of gastroparesis.M Ammar Kalas, Irene Sarosiek, Richard W McCallum> ;Expert Opinion on Pharmacotherapy. 2024 Apr 17
- 1 citationsAGA Clinical Practice Update on Diagnosis and Management of Cannabinoid Hyperemesis Syndrome: Commentary.Rubio-Tapia, A., McCallum, R., Camilleri, M.> ;Gastroenterology. 2024 Mar 5
- Metoclopramide Nasal Spray in Women with Symptomatic Diabetic Gastroparesis: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.Richard W McCallum, Henry P Parkman, Ronnie Fass, Bal R Bhandari, Marilyn R Carlson, Raymond D Buck> ;Clinical Gastroenterology and Hepatology. 2023 Nov 2
- Join now to see all
Authored Content
- Effectiveness of Bulking Agent (Solesta) Therapy in Fecal Incontinence in Patients Refractory to Conventional Therapies☆☆☆September 2017
Press Mentions
Real-World Data Analysis Reveals a Lower Risk of Tardive Dyskinesia (TD) with Metoclopramide Than Previously ReportedMay 23rd, 2022- TTUHSC El Paso Professor Elected to Local, National Medical OrganizationsJune 1st, 2021
- Evoke Pharma Announces a Fireside Chat with Key Opinion Leaders on the Treatment of GastroparesisMarch 30th, 2021
- Join now to see all
Grant Support
- New Diagnosis And Treatment Approaches For Patients Wit*National Institute Of Diabetes And Digestive And Kidney Diseases2008–2010
- New Diagnosis And Treatment Approaches For Patients Wit*National Institute Of Diabetes And Digestive And Kidney Diseases2008
- 11th Biennual Meeting Of The American Motility SocietyNational Institute Of Diabetes And Digestive And Kidney Diseases2000
- Electrical Stimulation To AID Gastric Motility In Gastroparesis PatientsNational Center For Research Resources1996–1997
- Effect Of Vasopressin On Gastric Myoelectric ActivityNational Center For Research Resources1996–1997
- Can Light Vection Effect Electrogastrogram &Induce Nausea In HumansNational Center For Research Resources1996–1997
Hospital Affiliations
University Medical Center of El PasoEl Paso, Texas
